[{"id":"ca9c53ec-c832-4b1c-9e81-bef149f09451","acronym":"","url":"https://clinicaltrials.gov/study/NCT04060394","created_at":"2021-01-18T19:54:03.680Z","updated_at":"2024-07-02T16:35:09.013Z","phase":"Phase 1/2","brief_title":"Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC","source_id_and_acronym":"NCT04060394","lead_sponsor":"Laekna Limited","biomarkers":" PIK3CA • PTEN • BRCA","pipe":" | ","alterations":" PTEN mutation • BRCA mutation","tags":["PIK3CA • PTEN • BRCA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PTEN mutation • BRCA mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e docetaxel • prednisone • afuresertib (LAE002) • LAE001"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 74","initiation":"Initiation: 09/13/2019","start_date":" 09/13/2019","primary_txt":" Primary completion: 12/27/2023","primary_completion_date":" 12/27/2023","study_txt":" Completion: 10/30/2024","study_completion_date":" 10/30/2024","last_update_posted":"2024-04-18"}]